Home › Funds › Allspring Global Investments Holdings, LLC › CRL
Allspring Global Investments Holdings, LLC position in CRL
CHARLES RIV LABS INTL INC · Health Care
Allspring Global Investments Holdings, LLC reported holding 887,518 shares of CRL (CHARLES RIV LABS INTL INC) in its Q3 2026 13F filing — a position valued at US$254.6M, representing 0.40% of its reported portfolio and ranking #50 among its reported holdings. Allspring Global Investments Holdings, LLC has disclosed CRL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Allspring Global Investments Holdings, LLC's CRL position evolved
Allspring Global Investments Holdings, LLC first disclosed a stake in CRL in Q3 2023 at 1,195,226 shares (US$234.2M). The position peaked in Q2 2026 at 1,905,247 shares, worth US$436.5M. Across 13 filings, Allspring Global Investments Holdings, LLC increased the stake 4 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 887,518 shares valued at US$254.6M — a reduction of -1,017,729 shares quarter over quarter.. Notable position changes include a 41% increase in Q3 2024 (shares fell 6% over the following quarter), a 29% increase in Q2 2025 (shares rose 3% over the following quarter), a 53% trim in Q3 2026 (shares rose 16% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.20M | $234.24M | New |
| Q4 2023 | 1.17M | $275.48M | Reduce |
| Q1 2024 | 1.12M | $303.14M | Reduce |
| Q2 2024 | 1.25M | $258.56M | Add |
| Q3 2024 | 1.76M | $346.82M | Add |
| Q4 2024 | 1.81M | $330.23M | Add |
| Q1 2025 | 1.77M | $259.07M | Reduce |
| Q2 2025 | 2.29M | $353.75M | Add |
| Q3 2025 | 2.18M | $371.30M | Reduce |
| Q4 2025 | 2.00M | $403.95M | Reduce |
| Q1 2026 | 1.99M | $348.63M | Hold |
| Q2 2026 | 1.91M | $436.47M | Reduce |
| Q3 2026 | 887.52K | $254.57M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CRL and 13F data
CRL (CHARLES RIV LABS INTL INC) is a Health Care company. 28 other funds we track also report a position in CRL — the largest reported positions include ARIEL INVESTMENTS, LLC (US$352.0M), EARNEST PARTNERS LLC (US$320.7M), COOKE & BIELER LP (US$127.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CRL
- ARIEL INVESTMENTS, LLC 1.19M sh · $352.05M · Q3 2026
- EARNEST PARTNERS LLC 1.09M sh · $320.67M · Q3 2026
- COOKE & BIELER LP 432.12K sh · $127.48M · Q3 2026
More on Allspring Global Investments Holdings, LLC
FAQ
How long has Allspring Global Investments Holdings, LLC held CRL?
Allspring Global Investments Holdings, LLC has disclosed CRL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Allspring Global Investments Holdings, LLC's current position in CRL?
As of Q3 2026, Allspring Global Investments Holdings, LLC holds 887.52K shares of CRL (CHARLES RIV LABS INTL INC), valued at $254.57M, representing 0.40% of its reported portfolio and ranking #50.
Has Allspring Global Investments Holdings, LLC been buying or selling CRL?
In the latest 13F filing (Q3 2026), Allspring Global Investments Holdings, LLC reduced its position in CRL. The position peaked in Q2 2026 at 1.91M shares.
Which other funds hold CRL?
Other major institutional holders of CRL include ARIEL INVESTMENTS, LLC, EARNEST PARTNERS LLC, COOKE & BIELER LP, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.